Carter Bankshares, Inc.
NASDAQ:CAREBanks - Regional
-$0.20 today
- Market cap
- $635.59M
- Beta
- 0.55
- P/E (TTM)
- 6.2
- EPS (TTM)
- $4.95
- Dividend yield
- 0.33%
Volume 0.19M
Average 0.32M
CARE Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
Carter Bankshares, Inc.NASDAQ: CARE
Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Investing cash flow declines year over year
Q1 FY2026 investing cash flow of $26.62M (cash outflow) fell 67.2% year over year, behind the -36.5% change in trailing-twelve-month investing cash flow. Sequentially, it rose 132.7% from the prior quarter. Over 3 fiscal years it compounded at -25.8% a year.
Context
- Investing cash flow amounted to 61.2% of revenue in FY2025, up 32.7 pp from a year earlier.
- Investing cash flow grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -67.2% toward the trailing-twelve-month pace of -36.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (155.91M) USD
- Year-over-year change
- -127.9%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (155.91M) | -127.9% |
| FY2024 | 2024-12-31 | (68.4M) | +77.7% |
| FY2023 | 2023-12-31 | (307.01M) | +19.6% |
| FY2022 | 2022-12-31 | (382.07M) | -259.2% |
| FY2021 | 2021-12-31 | (106.36M) | — |
Investing Cash Flow vs competitors
How CARE compares with its peers on the latest reported figures
- CARE's LTM Mar 2026 investing cash flow of $101.48M is the 7th largest of the 11 companies compared; the peer median is $54.54M.
- Its year-over-year change of -36.5% is the 7th highest of 11, against a peer median of +13.3%.
- Investing cash flow amounts to 31.7% of revenue for CARE, versus a peer median of 93.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $1.12B | +583.3% | — | 182.1% | |
| LTM Mar 2026 | $267.06M | -2014.4% | -41.2% | 126.1% | |
| LTM Mar 2026 | $250.82M | +433.2% | -36.1% | 122.0% | |
| LTM Mar 2026 | $232.46M | -44.3% | — | 161.5% | |
| LTM Mar 2026 | $171.4M | +29.3% | -25.6% | 90.8% | |
| LTM Mar 2026 | $169.29M | -2.7% | — | 96.6% | |
| LTM Mar 2026 | $101.48M | -36.5% | -25.8% | 31.7% | |
| LTM Mar 2026 | $97.05M | +82.5% | -25.2% | 79.1% | |
| LTM Mar 2026 | $67.79M | -70.1% | -12.7% | 27.3% | |
| LTM Mar 2026 | $66.79M | +165.1% | — | 27.5% | |
| LTM Mar 2026 | $41.29M | -333.2% | -32.9% | 48.0% | |
| Peer median (excluding CARE) | $54.54M | +13.3% | -29.3% | 93.7% | |
Competitors are the stored peer set for CARE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 31.59M | 50.12M | 23.38M | 24.52M | 31.36M |
| Depreciation & Amortization | 6.23M | 6.06M | 6.25M | 7.06M | 7.86M |
| Deferred Income Tax | 4.82M | 4.25M | 2.47M | 3.21M | 2.82M |
| Stock-Based Compensation | 1.04M | 1.31M | 1.56M | 1.75M | 2.07M |
| Change in Working Capital | 5.61M | (722K) | (1.43M) | 1.83M | (1.98M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 5.61M | (722K) | (1.43M) | 1.83M | (1.98M) |
| Other Non-Cash Items | 28.25M | 9.77M | 14.5M | (1.43M) | (2.27M) |
| Operating Cash Flow | 77.54M | 70.79M | 46.73M | 36.94M | 39.86M |
| Capital Expenditures | (8.48M) | (5.89M) | (9.8M) | (8.13M) | (8.06M) |
| Acquisitions (Net) | (73.92M) | 0 | 0 | 0 | 53.57M |
| Purchases of Investments | (466.65M) | (135.63M) | (24.94M) | (25.13M) | (63.68M) |
| Sales of Investments | 307.25M | 104.47M | 92.22M | 81.41M | 115.93M |
| Other Investing Activities | 135.45M | (345.02M) | (364.5M) | (116.55M) | (253.68M) |
| Investing Cash Flow | (106.36M) | (382.07M) | (307.01M) | (68.4M) | (155.91M) |
| Debt Repayment | (28M) | 173.55M | 194.98M | (323.4M) | 108.5M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (157K) | (42.93M) | (16.42M) | 0 | (20M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 92.83M | (50.27M) | 89.38M | 431.51M | 1.54M |
| Financing Cash Flow | 64.67M | 80.35M | 267.94M | 108.11M | 90.04M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 35.86M | (230.93M) | 7.66M | 76.64M | (26.01M) |
| Free Cash Flow | 69.05M | 64.9M | 36.93M | 28.81M | 31.81M |
Carter Bankshares, Inc.
NASDAQ:CARE
Intrinsic Alpha fair value
Locked
Current Price
$28.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.